Vandetanib Completed Phase 1 Trials for Colorectal Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00496509Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer
NCT00436072ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer